13-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “Glucagon Market By Product (Inject Glucagon, Nasal Glucagon, and Others), By Industry (Emergency Kits, General Use, Diagnostic & Motility, and Others)and By Sales Channel (Direct Sales and Distributor): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Glucagon market in 2019 was approximately USD 470 million. The market is expected to grow at a CAGR of 5.8% and is anticipated to reach around USD 700 million by 2026.
Glucagon is a pancreatic hormone that rapidly raises the blood glucose level in the body. Glucagon is also available as a medicine to treat low blood sugar levels in patients. The demand in Glucagon is expected to increase during the forecast period. Technological innovations, increased people's awareness about glucagon and diabetes and increased global glucagon adoption rates are some of the factors that drive growth on the market. In addition, the government's life science venture is projected to increase in the future for the global glucagon industry. Moreover, the increasing growth of the pharmaceutical industry in combination with price competition is projected to bring lucrative opportunities to the global glucagon industry. But the high price of Glucagon and its side effects, such as high blood pressure, allergic reactions, etc., may have negative effects on the world glucagon market growth in the next few years.
Browse the full “Glucagon Market By Product (Inject Glucagon, Nasal Glucagon, and Others), By Industry (Emergency Kits, General Use, Diagnostic & Motility, and Others)and By Sales Channel (Direct Sales and Distributor): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/glucagon-market-by-product-inject-glucagon-nasal-glucagon-722
The product segmentation of the industry is Inject Glucagon and Nasal Glucagon, the bulk of which in 2019 was Inject Glucagon and about USD 410 million in 2019. The growth in this segment is mainly due to the continuous developments in the market and the launching of new products. This section will be important during the forecast period.
Glucagon is segmented into emergency kits, general use, diagnostic and motility, etc. based on the industry level. In 2019, general use accounted for Glucagon's largest market share. Increasing demand for glucagon from and filed by pharmaceutical companies. Even from a marketing perspective, technology has plenty of space on the market to expand. Based on a simple cost analysis, this technology will only increase monetarily in the future. In addition, diagnosis & motility was the world's second-largest segment in 2019 and the forecast period is anticipated to fuel market growth.
By region, the North American region dominated the global glucagon market in 2019. Global growth in North America is owed to increased industrialization, scientific advances and the involvement of many pharmaceutical companies in North America, robust growth is expected in the forecast period.
Some of the essential players operating in the GLUCAGON market, but not restricted to Novo Nordisk, Eli Lilly, Fresenius Kabi AG, Torrent Laboratory, Inc., Taj Pharmaceuticals Ltd., Xeris Pharmaceuticals, Inc., UNITED BIOTECH (P) LTD., USV Private Limited, and others.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 470 Million |
Projected Market Size in 2026 |
USD 700 Million |
CAGR Growth Rate |
5.8% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Novo Nordisk, Eli Lilly, Fresenius Kabi AG, Torrent Laboratory, Inc., Taj Pharmaceuticals Ltd., Xeris Pharmaceuticals, Inc., UNITED BIOTECH (P) LTD., USV Private Limited, and others. |
Key Segment |
By Product, Industry, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
This report segments the Glucagon market as follows:
Global Glucagon Market: By Product Segmentation Analysis
- Inject Glucagon
- Nasal Glucagon
- Others
Global Glucagon Market: By Industry Segmentation Analysis
- Emergency Kits
- General Use
- Diagnostic & Motility
- Others
Global Glucagon Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
